Global and China Interleukin 1 (IL1) Market Insights, Forecast to 2026

Global and China Interleukin 1 (IL1) Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Interleukin 1 (IL1) Product Introduction
1.2 Market Segments
1.3 Key Interleukin 1 (IL1) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interleukin 1 (IL1) Market Size Growth Rate by Type
1.4.2 APX-002
1.4.3 Canakinumab
1.4.4 Diacerein CR
1.4.5 IR-1000
1.4.6 Others
1.5 Market by Application
1.5.1 Global Interleukin 1 (IL1) Market Size Growth Rate by Application
1.5.2 Esophageal Cancer
1.5.3 Fallopian Tube Cancer
1.5.4 Bladder Cancer
1.5.5 Bechcer Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Interleukin 1 (IL1) Market Size, Estimates and Forecasts
2.1.1 Global Interleukin 1 (IL1) Revenue 2015-2026
2.1.2 Global Interleukin 1 (IL1) Sales 2015-2026
2.2 Global Interleukin 1 (IL1), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Interleukin 1 (IL1) Historical Market Size by Region (2015-2020)
2.3.1 Global Interleukin 1 (IL1) Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Interleukin 1 (IL1) Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Interleukin 1 (IL1) Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Interleukin 1 (IL1) Sales Forecast by Region (2021-2026)
2.4.2 Global Interleukin 1 (IL1) Revenue Forecast by Region (2021-2026)
3 Global Interleukin 1 (IL1) Competitor Landscape by Players
3.1 Global Top Interleukin 1 (IL1) Sales by Manufacturers
3.1.1 Global Interleukin 1 (IL1) Sales by Manufacturers (2015-2020)
3.1.2 Global Interleukin 1 (IL1) Sales Market Share by Manufacturers (2015-2020)
3.2 Global Interleukin 1 (IL1) Manufacturers by Revenue
3.2.1 Global Interleukin 1 (IL1) Revenue by Manufacturers (2015-2020)
3.2.2 Global Interleukin 1 (IL1) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interleukin 1 (IL1) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interleukin 1 (IL1) Revenue in 2019
3.2.5 Global Interleukin 1 (IL1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Interleukin 1 (IL1) Price by Manufacturers
3.4 Global Interleukin 1 (IL1) Manufacturing Base Distribution, Product Types
3.4.1 Interleukin 1 (IL1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interleukin 1 (IL1) Product Type
3.4.3 Date of International Manufacturers Enter into Interleukin 1 (IL1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interleukin 1 (IL1) Market Size by Type (2015-2020)
4.1.1 Global Interleukin 1 (IL1) Sales by Type (2015-2020)
4.1.2 Global Interleukin 1 (IL1) Revenue by Type (2015-2020)
4.1.3 Interleukin 1 (IL1) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interleukin 1 (IL1) Market Size Forecast by Type (2021-2026)
4.2.1 Global Interleukin 1 (IL1) Sales Forecast by Type (2021-2026)
4.2.2 Global Interleukin 1 (IL1) Revenue Forecast by Type (2021-2026)
4.2.3 Interleukin 1 (IL1) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interleukin 1 (IL1) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Interleukin 1 (IL1) Market Size by Application (2015-2020)
5.1.1 Global Interleukin 1 (IL1) Sales by Application (2015-2020)
5.1.2 Global Interleukin 1 (IL1) Revenue by Application (2015-2020)
5.1.3 Interleukin 1 (IL1) Price by Application (2015-2020)
5.2 Interleukin 1 (IL1) Market Size Forecast by Application (2021-2026)
5.2.1 Global Interleukin 1 (IL1) Sales Forecast by Application (2021-2026)
5.2.2 Global Interleukin 1 (IL1) Revenue Forecast by Application (2021-2026)
5.2.3 Global Interleukin 1 (IL1) Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
6.1.1 China Interleukin 1 (IL1) Sales YoY Growth 2015-2026
6.1.2 China Interleukin 1 (IL1) Revenue YoY Growth 2015-2026
6.1.3 China Interleukin 1 (IL1) Market Share in Global Market 2015-2026
6.2 China Interleukin 1 (IL1) Market Size by Players (International and Local Players)
6.2.1 China Top Interleukin 1 (IL1) Players by Sales (2015-2020)
6.2.2 China Top Interleukin 1 (IL1) Players by Revenue (2015-2020)
6.3 China Interleukin 1 (IL1) Historic Market Review by Type (2015-2020)
6.3.1 China Interleukin 1 (IL1) Sales Market Share by Type (2015-2020)
6.3.2 China Interleukin 1 (IL1) Revenue Market Share by Type (2015-2020)
6.3.3 China Interleukin 1 (IL1) Price by Type (2015-2020)
6.4 China Interleukin 1 (IL1) Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Interleukin 1 (IL1) Sales Forecast by Type (2021-2026)
6.4.2 China Interleukin 1 (IL1) Revenue Forecast by Type (2021-2026)
6.4.3 China Interleukin 1 (IL1) Price Forecast by Type (2021-2026)
6.5 China Interleukin 1 (IL1) Historic Market Review by Application (2015-2020)
6.5.1 China Interleukin 1 (IL1) Sales Market Share by Application (2015-2020)
6.5.2 China Interleukin 1 (IL1) Revenue Market Share by Application (2015-2020)
6.5.3 China Interleukin 1 (IL1) Price by Application (2015-2020)
6.6 China Interleukin 1 (IL1) Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Interleukin 1 (IL1) Sales Forecast by Application (2021-2026)
6.6.2 China Interleukin 1 (IL1) Revenue Forecast by Application (2021-2026)
6.6.3 China Interleukin 1 (IL1) Price Forecast by Application (2021-2026)
7 North America
7.1 North America Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
7.2 North America Interleukin 1 (IL1) Market Facts & Figures by Country
7.2.1 North America Interleukin 1 (IL1) Sales by Country (2015-2020)
7.2.2 North America Interleukin 1 (IL1) Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
8.2 Europe Interleukin 1 (IL1) Market Facts & Figures by Country
8.2.1 Europe Interleukin 1 (IL1) Sales by Country
8.2.2 Europe Interleukin 1 (IL1) Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
9.2 Asia Pacific Interleukin 1 (IL1) Market Facts & Figures by Country
9.2.1 Asia Pacific Interleukin 1 (IL1) Sales by Region (2015-2020)
9.2.2 Asia Pacific Interleukin 1 (IL1) Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
10.2 Latin America Interleukin 1 (IL1) Market Facts & Figures by Country
10.2.1 Latin America Interleukin 1 (IL1) Sales by Country
10.2.2 Latin America Interleukin 1 (IL1) Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Interleukin 1 (IL1) Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Interleukin 1 (IL1) Market Facts & Figures by Country
11.2.1 Middle East and Africa Interleukin 1 (IL1) Sales by Country
11.2.2 Middle East and Africa Interleukin 1 (IL1) Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Optimum Therapeutics LLC
12.1.1 Optimum Therapeutics LLC Corporation Information
12.1.2 Optimum Therapeutics LLC Description and Business Overview
12.1.3 Optimum Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Products Offered
12.1.5 Optimum Therapeutics LLC Recent Development
12.2 Orphit SAS
12.2.1 Orphit SAS Corporation Information
12.2.2 Orphit SAS Description and Business Overview
12.2.3 Orphit SAS Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Orphit SAS Interleukin 1 (IL1) Products Offered
12.2.5 Orphit SAS Recent Development
12.3 Peptinov SAS
12.3.1 Peptinov SAS Corporation Information
12.3.2 Peptinov SAS Description and Business Overview
12.3.3 Peptinov SAS Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Peptinov SAS Interleukin 1 (IL1) Products Offered
12.3.5 Peptinov SAS Recent Development
12.4 AbbVie Inc
12.4.1 AbbVie Inc Corporation Information
12.4.2 AbbVie Inc Description and Business Overview
12.4.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AbbVie Inc Interleukin 1 (IL1) Products Offered
12.4.5 AbbVie Inc Recent Development
12.5 Swedish Orphan Biovitrum AB
12.5.1 Swedish Orphan Biovitrum AB Corporation Information
12.5.2 Swedish Orphan Biovitrum AB Description and Business Overview
12.5.3 Swedish Orphan Biovitrum AB Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Products Offered
12.5.5 Swedish Orphan Biovitrum AB Recent Development
12.6 TWi Biotechnology Inc
12.6.1 TWi Biotechnology Inc Corporation Information
12.6.2 TWi Biotechnology Inc Description and Business Overview
12.6.3 TWi Biotechnology Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 TWi Biotechnology Inc Interleukin 1 (IL1) Products Offered
12.6.5 TWi Biotechnology Inc Recent Development
12.7 XBiotech Inc
12.7.1 XBiotech Inc Corporation Information
12.7.2 XBiotech Inc Description and Business Overview
12.7.3 XBiotech Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 XBiotech Inc Interleukin 1 (IL1) Products Offered
12.7.5 XBiotech Inc Recent Development
12.8 Cell Medica Ltd
12.8.1 Cell Medica Ltd Corporation Information
12.8.2 Cell Medica Ltd Description and Business Overview
12.8.3 Cell Medica Ltd Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Cell Medica Ltd Interleukin 1 (IL1) Products Offered
12.8.5 Cell Medica Ltd Recent Development
12.9 Exicure Inc
12.9.1 Exicure Inc Corporation Information
12.9.2 Exicure Inc Description and Business Overview
12.9.3 Exicure Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Exicure Inc Interleukin 1 (IL1) Products Offered
12.9.5 Exicure Inc Recent Development
12.10 Immune Response BioPharma Inc
12.10.1 Immune Response BioPharma Inc Corporation Information
12.10.2 Immune Response BioPharma Inc Description and Business Overview
12.10.3 Immune Response BioPharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Immune Response BioPharma Inc Interleukin 1 (IL1) Products Offered
12.10.5 Immune Response BioPharma Inc Recent Development
12.11 Optimum Therapeutics LLC
12.11.1 Optimum Therapeutics LLC Corporation Information
12.11.2 Optimum Therapeutics LLC Description and Business Overview
12.11.3 Optimum Therapeutics LLC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Products Offered
12.11.5 Optimum Therapeutics LLC Recent Development
12.12 Omnitura Therapeutics Inc
12.12.1 Omnitura Therapeutics Inc Corporation Information
12.12.2 Omnitura Therapeutics Inc Description and Business Overview
12.12.3 Omnitura Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Omnitura Therapeutics Inc Products Offered
12.12.5 Omnitura Therapeutics Inc Recent Development
12.13 Opsona Therapeutics Ltd
12.13.1 Opsona Therapeutics Ltd Corporation Information
12.13.2 Opsona Therapeutics Ltd Description and Business Overview
12.13.3 Opsona Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Opsona Therapeutics Ltd Products Offered
12.13.5 Opsona Therapeutics Ltd Recent Development
12.14 Anacor Pharmaceuticals Inc
12.14.1 Anacor Pharmaceuticals Inc Corporation Information
12.14.2 Anacor Pharmaceuticals Inc Description and Business Overview
12.14.3 Anacor Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Anacor Pharmaceuticals Inc Products Offered
12.14.5 Anacor Pharmaceuticals Inc Recent Development
12.15 Apexigen Inc
12.15.1 Apexigen Inc Corporation Information
12.15.2 Apexigen Inc Description and Business Overview
12.15.3 Apexigen Inc Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Apexigen Inc Products Offered
12.15.5 Apexigen Inc Recent Development
12.16 R Pharm
12.16.1 R Pharm Corporation Information
12.16.2 R Pharm Description and Business Overview
12.16.3 R Pharm Sales, Revenue and Gross Margin (2015-2020)
12.16.4 R Pharm Products Offered
12.16.5 R Pharm Recent Development
12.17 Regeneron Pharmaceuticals Inc
12.17.1 Regeneron Pharmaceuticals Inc Corporation Information
12.17.2 Regeneron Pharmaceuticals Inc Description and Business Overview
12.17.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Regeneron Pharmaceuticals Inc Products Offered
12.17.5 Regeneron Pharmaceuticals Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Interleukin 1 (IL1) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interleukin 1 (IL1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Interleukin 1 (IL1) Market Segments
Table 2. Ranking of Global Top Interleukin 1 (IL1) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interleukin 1 (IL1) Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of APX-002
Table 5. Major Manufacturers of Canakinumab
Table 6. Major Manufacturers of Diacerein CR
Table 7. Major Manufacturers of IR-1000
Table 8. Major Manufacturers of Others
Table 9. Global Interleukin 1 (IL1) Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Interleukin 1 (IL1) Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Interleukin 1 (IL1) Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Interleukin 1 (IL1) Sales Market Share by Regions (2015-2020)
Table 13. Global Interleukin 1 (IL1) Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Interleukin 1 (IL1) Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Interleukin 1 (IL1) Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Interleukin 1 (IL1) Sales Share by Manufacturers (2015-2020)
Table 17. Global Interleukin 1 (IL1) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Interleukin 1 (IL1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin 1 (IL1) as of 2019)
Table 19. Interleukin 1 (IL1) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Interleukin 1 (IL1) Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Interleukin 1 (IL1) Price (2015-2020) (USD/Pcs)
Table 22. Interleukin 1 (IL1) Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Interleukin 1 (IL1) Product Type
Table 24. Date of International Manufacturers Enter into Interleukin 1 (IL1) Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Interleukin 1 (IL1) Sales by Type (2015-2020) (K Pcs)
Table 27. Global Interleukin 1 (IL1) Sales Share by Type (2015-2020)
Table 28. Global Interleukin 1 (IL1) Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Interleukin 1 (IL1) Revenue Share by Type (2015-2020)
Table 30. Interleukin 1 (IL1) Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Interleukin 1 (IL1) Sales Share by Type (2021-2026)
Table 32. Global Interleukin 1 (IL1) Sales by Application (2015-2020) (K Pcs)
Table 33. Global Interleukin 1 (IL1) Sales Share by Application (2015-2020)
Table 34. Global Interleukin 1 (IL1) Sales Share by Application (2021-2026)
Table 35. Global Interleukin 1 (IL1) Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Interleukin 1 (IL1) Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Interleukin 1 (IL1) Revenue Market Share Forecast by Application (2021-2026)
Table 38. China Interleukin 1 (IL1) Sales (K Pcs) of Key Companies (2015-2020)
Table 39. China Interleukin 1 (IL1) Sales Share by Company (2015-2020)
Table 40. China Interleukin 1 (IL1) Revenue (US$ Million) by Company (2015-2020)
Table 41. China Interleukin 1 (IL1) Sales (K Pcs) by Type (2015-2020)
Table 42. China Interleukin 1 (IL1) Sales Share by Type (2015-2020)
Table 43. China Interleukin 1 (IL1) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China Interleukin 1 (IL1) Price (K Pcs) by Type (2015-2020)
Table 45. China Interleukin 1 (IL1) Sales (K Pcs) by Type (2021-2026)
Table 46. China Interleukin 1 (IL1) Sales Share by Type (2021-2026)
Table 47. China Interleukin 1 (IL1) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China Interleukin 1 (IL1) Revenue Share by Type (2021-2026)
Table 49. China Interleukin 1 (IL1) Price (K Pcs) by Type (2021-2026)
Table 50. China Interleukin 1 (IL1) Sales (K Pcs) by Application (2015-2020)
Table 51. China Interleukin 1 (IL1) Sales Share by Application (2015-2020)
Table 52. China Interleukin 1 (IL1) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China Interleukin 1 (IL1) Sales (K Pcs) by Application (2021-2026)
Table 54. China Interleukin 1 (IL1) Sales Share by Application (2021-2026)
Table 55. China Interleukin 1 (IL1) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China Interleukin 1 (IL1) Revenue Share by Application (2021-2026)
Table 57. North America Interleukin 1 (IL1) Sales by Country (2015-2020) (K Pcs)
Table 58. North America Interleukin 1 (IL1) Sales Market Share by Country (2015-2020)
Table 59. North America Interleukin 1 (IL1) Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Interleukin 1 (IL1) Revenue Market Share by Country (2015-2020)
Table 61. Europe Interleukin 1 (IL1) Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Interleukin 1 (IL1) Sales Market Share by Country (2015-2020)
Table 63. Europe Interleukin 1 (IL1) Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Interleukin 1 (IL1) Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Interleukin 1 (IL1) Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Interleukin 1 (IL1) Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Interleukin 1 (IL1) Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Interleukin 1 (IL1) Revenue Market Share by Region (2015-2020)
Table 69. Latin America Interleukin 1 (IL1) Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Interleukin 1 (IL1) Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Interleukin 1 (IL1) Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Interleukin 1 (IL1) Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Interleukin 1 (IL1) Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Interleukin 1 (IL1) Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Interleukin 1 (IL1) Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Interleukin 1 (IL1) Revenue Market Share by Country (2015-2020)
Table 77. Optimum Therapeutics LLC Corporation Information
Table 78. Optimum Therapeutics LLC Description and Business Overview
Table 79. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Optimum Therapeutics LLC Interleukin 1 (IL1) Product
Table 81. Optimum Therapeutics LLC Recent Development
Table 82. Orphit SAS Corporation Information
Table 83. Orphit SAS Description and Business Overview
Table 84. Orphit SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Orphit SAS Product
Table 86. Orphit SAS Recent Development
Table 87. Peptinov SAS Corporation Information
Table 88. Peptinov SAS Description and Business Overview
Table 89. Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Peptinov SAS Product
Table 91. Peptinov SAS Recent Development
Table 92. AbbVie Inc Corporation Information
Table 93. AbbVie Inc Description and Business Overview
Table 94. AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. AbbVie Inc Product
Table 96. AbbVie Inc Recent Development
Table 97. Swedish Orphan Biovitrum AB Corporation Information
Table 98. Swedish Orphan Biovitrum AB Description and Business Overview
Table 99. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Swedish Orphan Biovitrum AB Product
Table 101. Swedish Orphan Biovitrum AB Recent Development
Table 102. TWi Biotechnology Inc Corporation Information
Table 103. TWi Biotechnology Inc Description and Business Overview
Table 104. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. TWi Biotechnology Inc Product
Table 106. TWi Biotechnology Inc Recent Development
Table 107. XBiotech Inc Corporation Information
Table 108. XBiotech Inc Description and Business Overview
Table 109. XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. XBiotech Inc Product
Table 111. XBiotech Inc Recent Development
Table 112. Cell Medica Ltd Corporation Information
Table 113. Cell Medica Ltd Description and Business Overview
Table 114. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Cell Medica Ltd Product
Table 116. Cell Medica Ltd Recent Development
Table 117. Exicure Inc Corporation Information
Table 118. Exicure Inc Description and Business Overview
Table 119. Exicure Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Exicure Inc Product
Table 121. Exicure Inc Recent Development
Table 122. Immune Response BioPharma Inc Corporation Information
Table 123. Immune Response BioPharma Inc Description and Business Overview
Table 124. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Immune Response BioPharma Inc Product
Table 126. Immune Response BioPharma Inc Recent Development
Table 127. Novartis AG Corporation Information
Table 128. Novartis AG Description and Business Overview
Table 129. Novartis AG Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Novartis AG Product
Table 131. Novartis AG Recent Development
Table 132. Omnitura Therapeutics Inc Corporation Information
Table 133. Omnitura Therapeutics Inc Description and Business Overview
Table 134. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Omnitura Therapeutics Inc Product
Table 136. Omnitura Therapeutics Inc Recent Development
Table 137. Opsona Therapeutics Ltd Corporation Information
Table 138. Opsona Therapeutics Ltd Description and Business Overview
Table 139. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Opsona Therapeutics Ltd Product
Table 141. Opsona Therapeutics Ltd Recent Development
Table 142. Anacor Pharmaceuticals Inc Corporation Information
Table 143. Anacor Pharmaceuticals Inc Description and Business Overview
Table 144. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Anacor Pharmaceuticals Inc Product
Table 146. Anacor Pharmaceuticals Inc Recent Development
Table 147. Apexigen Inc Corporation Information
Table 148. Apexigen Inc Description and Business Overview
Table 149. Apexigen Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Apexigen Inc Product
Table 151. Apexigen Inc Recent Development
Table 152. R Pharm Corporation Information
Table 153. R Pharm Description and Business Overview
Table 154. R Pharm Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. R Pharm Product
Table 156. R Pharm Recent Development
Table 157. Regeneron Pharmaceuticals Inc Corporation Information
Table 158. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 159. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 160. Regeneron Pharmaceuticals Inc Product
Table 161. Regeneron Pharmaceuticals Inc Recent Development
Table 162. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 163. Key Challenges
Table 164. Market Risks
Table 165. Main Points Interviewed from Key Interleukin 1 (IL1) Players
Table 166. Interleukin 1 (IL1) Customers List
Table 167. Interleukin 1 (IL1) Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin 1 (IL1) Product Picture
Figure 2. Global Interleukin 1 (IL1) Sales Market Share by Type in 2020 & 2026
Figure 3. APX-002 Product Picture
Figure 4. Canakinumab Product Picture
Figure 5. Diacerein CR Product Picture
Figure 6. IR-1000 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Interleukin 1 (IL1) Sales Market Share by Application in 2020 & 2026
Figure 9. Esophageal Cancer
Figure 10. Fallopian Tube Cancer
Figure 11. Bladder Cancer
Figure 12. Bechcer Disease
Figure 13. Others
Figure 14. Interleukin 1 (IL1) Report Years Considered
Figure 15. Global Interleukin 1 (IL1) Market Size 2015-2026 (US$ Million)
Figure 16. Global Interleukin 1 (IL1) Sales 2015-2026 (K Pcs)
Figure 17. Global Interleukin 1 (IL1) Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Interleukin 1 (IL1) Sales Market Share by Region (2015-2020)
Figure 19. Global Interleukin 1 (IL1) Sales Market Share by Region in 2019
Figure 20. Global Interleukin 1 (IL1) Revenue Market Share by Region (2015-2020)
Figure 21. Global Interleukin 1 (IL1) Revenue Market Share by Region in 2019
Figure 22. Global Interleukin 1 (IL1) Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Interleukin 1 (IL1) Revenue in 2019
Figure 24. Interleukin 1 (IL1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Interleukin 1 (IL1) Sales Market Share by Type (2015-2020)
Figure 26. Global Interleukin 1 (IL1) Sales Market Share by Type in 2019
Figure 27. Global Interleukin 1 (IL1) Revenue Market Share by Type (2015-2020)
Figure 28. Global Interleukin 1 (IL1) Revenue Market Share by Type in 2019
Figure 29. Global Interleukin 1 (IL1) Market Share by Price Range (2015-2020)
Figure 30. Global Interleukin 1 (IL1) Sales Market Share by Application (2015-2020)
Figure 31. Global Interleukin 1 (IL1) Sales Market Share by Application in 2019
Figure 32. Global Interleukin 1 (IL1) Revenue Market Share by Application (2015-2020)
Figure 33. Global Interleukin 1 (IL1) Revenue Market Share by Application in 2019
Figure 34. China Interleukin 1 (IL1) Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. China Interleukin 1 (IL1) Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. China Interleukin 1 (IL1) Market Share in Global Market 2015-2026
Figure 37. China 5 and 10 Largest Interleukin 1 (IL1) Players Market Share by Revenue in Interleukin 1 (IL1) in 2019
Figure 38. China Interleukin 1 (IL1) Revenue Share by Type (2015-2020)
Figure 39. China Interleukin 1 (IL1) Revenue Growth Rate by Type in 2015 & 2019
Figure 40. China Interleukin 1 (IL1) Revenue Share by Application (2015-2020)
Figure 41. China Interleukin 1 (IL1) Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Interleukin 1 (IL1) Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Interleukin 1 (IL1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Interleukin 1 (IL1) Sales Market Share by Country in 2019
Figure 45. North America Interleukin 1 (IL1) Revenue Market Share by Country in 2019
Figure 46. U.S. Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Interleukin 1 (IL1) Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Interleukin 1 (IL1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Interleukin 1 (IL1) Sales Market Share by Country in 2019
Figure 53. Europe Interleukin 1 (IL1) Revenue Market Share by Country in 2019
Figure 54. Germany Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Interleukin 1 (IL1) Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Interleukin 1 (IL1) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Interleukin 1 (IL1) Sales Market Share by Region in 2019
Figure 67. Asia Pacific Interleukin 1 (IL1) Revenue Market Share by Region in 2019
Figure 68. China Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Interleukin 1 (IL1) Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Interleukin 1 (IL1) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. In

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs